Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
Scope of the Report:
Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar.
There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes.
We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America.
The Industry is affected by the economic development level and policy, so it's important to put an eye to economic indexes and leaders' prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.
The worldwide market for Insulin Glargine is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 7240 million US$ in 2024, from 5690 million US$ in 2019, according to a new WMR study.
This report focuses on the Insulin Glargine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi-Aventis
Ganlee
Biocon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single Dose Vial
Pre-filled Syringe
Market Segment by Applications, can be divided into
Treat type2 diabetes
Treat type1 diabetes
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Glargine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin Glargine, with price, sales, revenue and global market share of Insulin Glargine in 2017 and 2018.
Chapter 3, the Insulin Glargine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Glargine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Insulin Glargine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Insulin Glargine Introduction
1.2 Market Analysis by Type
1.2.1 Single Dose Vial
1.2.2 Pre-filled Syringe
1.3 Market Analysis by Applications
1.3.1 Treat type2 diabetes
1.3.2 Treat type1 diabetes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Business Overview
2.1.2 Insulin Glargine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi-Aventis Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Ganlee
2.2.1 Business Overview
2.2.2 Insulin Glargine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ganlee Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Biocon
2.3.1 Business Overview
2.3.2 Insulin Glargine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Insulin Glargine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Insulin Glargine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Insulin Glargine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Glargine Manufacturer Market Share in 2018
3.3.2 Top 6 Insulin Glargine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Insulin Glargine Market Analysis by Regions
4.1 Global Insulin Glargine Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Glargine Sales and Market Share by Regions (2014-2019)
4.1.2 Global Insulin Glargine Revenue and Market Share by Regions (2014-2019)
4.2 North America Insulin Glargine Sales and Growth Rate (2014-2019)
4.3 Europe Insulin Glargine Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Insulin Glargine Sales and Growth Rate (2014-2019)
4.5 South America Insulin Glargine Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Insulin Glargine Sales and Growth Rate (2014-2019)
5 North America Insulin Glargine by Country
5.1 North America Insulin Glargine Sales, Revenue and Market Share by Country
5.1.1 North America Insulin Glargine Sales and Market Share by Country (2014-2019)
5.1.2 North America Insulin Glargine Revenue and Market Share by Country (2014-2019)
5.2 United States Insulin Glargine Sales and Growth Rate (2014-2019)
5.3 Canada Insulin Glargine Sales and Growth Rate (2014-2019)
5.4 Mexico Insulin Glargine Sales and Growth Rate (2014-2019)
6 Europe Insulin Glargine by Country
6.1 Europe Insulin Glargine Sales, Revenue and Market Share by Country
6.1.1 Europe Insulin Glargine Sales and Market Share by Country (2014-2019)
6.1.2 Europe Insulin Glargine Revenue and Market Share by Country (2014-2019)
6.2 Germany Insulin Glargine Sales and Growth Rate (2014-2019)
6.3 UK Insulin Glargine Sales and Growth Rate (2014-2019)
6.4 France Insulin Glargine Sales and Growth Rate (2014-2019)
6.5 Russia Insulin Glargine Sales and Growth Rate (2014-2019)
6.6 Italy Insulin Glargine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Insulin Glargine by Country
7.1 Asia-Pacific Insulin Glargine Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Insulin Glargine Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Insulin Glargine Revenue and Market Share by Country (2014-2019)
7.2 China Insulin Glargine Sales and Growth Rate (2014-2019)
7.3 Japan Insulin Glargine Sales and Growth Rate (2014-2019)
7.4 Korea Insulin Glargine Sales and Growth Rate (2014-2019)
7.5 India Insulin Glargine Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Insulin Glargine Sales and Growth Rate (2014-2019)
8 South America Insulin Glargine by Country
8.1 South America Insulin Glargine Sales, Revenue and Market Share by Country
8.1.1 South America Insulin Glargine Sales and Market Share by Country (2014-2019)
8.1.2 South America Insulin Glargine Revenue and Market Share by Country (2014-2019)
8.2 Brazil Insulin Glargine Sales and Growth Rate (2014-2019)
8.3 Argentina Insulin Glargine Sales and Growth Rate (2014-2019)
8.4 Colombia Insulin Glargine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Insulin Glargine by Countries
9.1 Middle East and Africa Insulin Glargine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Insulin Glargine Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Insulin Glargine Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Insulin Glargine Sales and Growth Rate (2014-2019)
9.3 Turkey Insulin Glargine Sales and Growth Rate (2014-2019)
9.4 Egypt Insulin Glargine Sales and Growth Rate (2014-2019)
9.5 Nigeria Insulin Glargine Sales and Growth Rate (2014-2019)
9.6 South Africa Insulin Glargine Sales and Growth Rate (2014-2019)
10 Global Insulin Glargine Market Segment by Type
10.1 Global Insulin Glargine Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Insulin Glargine Sales and Market Share by Type (2014-2019)
10.1.2 Global Insulin Glargine Revenue and Market Share by Type (2014-2019)
10.2 Single Dose Vial Sales Growth and Price
10.2.1 Global Single Dose Vial Sales Growth (2014-2019)
10.2.2 Global Single Dose Vial Price (2014-2019)
10.3 Pre-filled Syringe Sales Growth and Price
10.3.1 Global Pre-filled Syringe Sales Growth (2014-2019)
10.3.2 Global Pre-filled Syringe Price (2014-2019)
11 Global Insulin Glargine Market Segment by Application
11.1 Global Insulin Glargine Sales Market Share by Application (2014-2019)
11.2 Treat type2 diabetes Sales Growth (2014-2019)
11.3 Treat type1 diabetes Sales Growth (2014-2019)
12 Insulin Glargine Market Forecast (2019-2024)
12.1 Global Insulin Glargine Sales, Revenue and Growth Rate (2019-2024)
12.2 Insulin Glargine Market Forecast by Regions (2019-2024)
12.2.1 North America Insulin Glargine Market Forecast (2019-2024)
12.2.2 Europe Insulin Glargine Market Forecast (2019-2024)
12.2.3 Asia-Pacific Insulin Glargine Market Forecast (2019-2024)
12.2.4 South America Insulin Glargine Market Forecast (2019-2024)
12.2.5 Middle East and Africa Insulin Glargine Market Forecast (2019-2024)
12.3 Insulin Glargine Market Forecast by Type (2019-2024)
12.3.1 Global Insulin Glargine Sales Forecast by Type (2019-2024)
12.3.2 Global Insulin Glargine Market Share Forecast by Type (2019-2024)
12.4 Insulin Glargine Market Forecast by Application (2019-2024)
12.4.1 Global Insulin Glargine Sales Forecast by Application (2019-2024)
12.4.2 Global Insulin Glargine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Insulin Glargine Picture
Table Product Specifications of Insulin Glargine
Figure Global Sales Market Share of Insulin Glargine by Types in 2018
Table Insulin Glargine Types for Major Manufacturers
Figure Single Dose Vial Picture
Figure Pre-filled Syringe Picture
Figure Insulin Glargine Sales Market Share by Applications in 2018
Figure Treat type2 diabetes Picture
Figure Treat type1 diabetes Picture
Figure United States Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure France Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure UK Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure China Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure India Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Insulin Glargine Revenue (Value) and Growth Rate (2014-2024)
Table Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi-Aventis Insulin Glargine Type and Applications
Table Sanofi-Aventis Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ganlee Basic Information, Manufacturing Base and Competitors
Table Ganlee Insulin Glargine Type and Applications
Table Ganlee Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Insulin Glargine Type and Applications
Table Biocon Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Insulin Glargine Sales by Manufacturer (2017-2018)
Figure Global Insulin Glargine Sales Market Share by Manufacturer in 2017
Figure Global Insulin Glargine Sales Market Share by Manufacturer in 2018
Table Global Insulin Glargine Revenue by Manufacturer (2017-2018)
Figure Global Insulin Glargine Revenue Market Share by Manufacturer in 2017
Figure Global Insulin Glargine Revenue Market Share by Manufacturer in 2018
Figure Top 3 Insulin Glargine Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Insulin Glargine Manufacturer (Revenue) Market Share in 2018
Figure Global Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Global Insulin Glargine Revenue and Growth Rate (2014-2019)
Table Global Insulin Glargine Sales by Regions (2014-2019)
Table Global Insulin Glargine Sales Market Share by Regions (2014-2019)
Table Global Insulin Glargine Revenue by Regions (2014-2019)
Figure Global Insulin Glargine Revenue Market Share by Regions in 2014
Figure Global Insulin Glargine Revenue Market Share by Regions in 2018
Figure North America Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Europe Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Insulin Glargine Sales and Growth Rate (2014-2019)
Figure South America Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Insulin Glargine Sales and Growth Rate (2014-2019)
Figure North America Insulin Glargine Revenue and Growth Rate (2014-2019)
Table North America Insulin Glargine Sales by Countries (2014-2019)
Table North America Insulin Glargine Sales Market Share by Countries (2014-2019)
Figure North America Insulin Glargine Sales Market Share by Countries in 2014
Figure North America Insulin Glargine Sales Market Share by Countries in 2018
Table North America Insulin Glargine Revenue by Countries (2014-2019)
Table North America Insulin Glargine Revenue Market Share by Countries (2014-2019)
Figure North America Insulin Glargine Revenue Market Share by Countries in 2014
Figure North America Insulin Glargine Revenue Market Share by Countries in 2018
Figure United States Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Canada Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Mexico Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Europe Insulin Glargine Revenue and Growth Rate (2014-2019)
Table Europe Insulin Glargine Sales by Countries (2014-2019)
Table Europe Insulin Glargine Sales Market Share by Countries (2014-2019)
Table Europe Insulin Glargine Revenue by Countries (2014-2019)
Figure Europe Insulin Glargine Revenue Market Share by Countries in 2017
Figure Europe Insulin Glargine Revenue Market Share by Countries in 2018
Figure Germany Insulin Glargine Sales and Growth Rate (2014-2019)
Figure UK Insulin Glargine Sales and Growth Rate (2014-2019)
Figure France Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Russia Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Italy Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Insulin Glargine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Insulin Glargine Sales by Countries (2014-2019)
Table Asia-Pacific Insulin Glargine Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Insulin Glargine Sales Market Share by Countries 2018
Table Asia-Pacific Insulin Glargine Revenue by Countries (2014-2019)
Figure Asia-Pacific Insulin Glargine Revenue Market Share by Countries 2018
Figure China Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Japan Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Korea Insulin Glargine Sales and Growth Rate (2014-2019)
Figure India Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Southeast Asia Insulin Glargine Sales and Growth Rate (2014-2019)
Figure South America Insulin Glargine Revenue and Growth Rate (2014-2019)
Table South America Insulin Glargine Sales by Countries (2014-2019)
Table South America Insulin Glargine Sales Market Share by Countries (2014-2019)
Figure South America Insulin Glargine Sales Market Share by Countries in 2018
Table South America Insulin Glargine Revenue by Countries (2014-2019)
Table South America Insulin Glargine Revenue Market Share by Countries (2014-2019)
Figure South America Insulin Glargine Revenue Market Share by Countries in 2018
Figure Brazil Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Argentina Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Colombia Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Insulin Glargine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Insulin Glargine Sales by Countries (2014-2019)
Table Middle East and Africa Insulin Glargine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Insulin Glargine Sales Market Share by Countries in 2018
Table Middle East and Africa Insulin Glargine Revenue by Countries (2014-2019)
Table Middle East and Africa Insulin Glargine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Insulin Glargine Revenue Market Share by Countries in 2014
Figure Middle East and Africa Insulin Glargine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Insulin Glargine Sales and Growth Rate (2014-2019)
Figure UAE Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Egypt Insulin Glargine Sales and Growth Rate (2014-2019)
Figure Nigeria Insulin Glargine Sales and Growth Rate (2014-2019)
Figure South Africa Insulin Glargine Sales and Growth Rate (2014-2019)
Table Global Insulin Glargine Sales by Type (2014-2019)
Table Global Insulin Glargine Sales Share by Type (2014-2019)
Table Global Insulin Glargine Revenue by Type (2014-2019)
Table Global Insulin Glargine Revenue Share by Type (2014-2019)
Figure Global Single Dose Vial Sales Growth (2014-2019)
Figure Global Single Dose Vial Price (2014-2019)
Figure Global Pre-filled Syringe Sales Growth (2014-2019)
Figure Global Pre-filled Syringe Price (2014-2019)
Table Global Insulin Glargine Sales by Application (2014-2019)
Table Global Insulin Glargine Sales Share by Application (2014-2019)
Figure Global Treat type1 diabetes Sales Growth (2014-2019)
Figure Global Insulin Glargine Sales, Revenue and Growth Rate (2019-2024)
Table Global Insulin Glargine Sales Forecast by Regions (2019-2024)
Table Global Insulin Glargine Market Share Forecast by Regions (2019-2024)
Figure North America Sales Insulin Glargine Market Forecast (2019-2024)
Figure Europe Sales Insulin Glargine Market Forecast (2019-2024)
Figure Asia-Pacific Sales Insulin Glargine Market Forecast (2019-2024)
Figure South America Sales Insulin Glargine Market Forecast (2019-2024)
Figure Middle East and Africa Sales Insulin Glargine Market Forecast (2019-2024)
Table Global Insulin Glargine Sales Forecast by Type (2019-2024)
Table Global Insulin Glargine Market Share Forecast by Type (2019-2024)
Table Global Insulin Glargine Sales Forecast by Application (2019-2024)
Table Global Insulin Glargine Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
Request Sample 
Request Discount 
Inquire Before Buy
